SUMMAR; Marshall L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUMMAR; Marshall L..The latest application filed is for "citrulline for treatment of sickle cell crisis".

Company Profile

3.10.15

SUMMAR; Marshall L. - Washington DC
Summar; Marshall L. - Brentwood TN US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Citrulline For Treatment Of Sickle Cell Crisis App 20220304966 - SUMMAR; Marshall L. ; et al.	2022-09-29
Citrulline for treatment of sickle cell crisis Grant 11,351,135 - Summar , et al. June 7, 2	2022-06-07
Intravenous administration of citrulline during surgery Grant 10,525,026 - Summar , et al. J	2020-01-07
Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage Grant 10,500,181 - Summar , et al. Dec	2019-12-10
Sequelae of cardiopulmonary bypass-induced pulmonary injury Grant 10,265,286 - Summar , et al.	2019-04-23
Methods And Compositions For Treatment For Coronary And Arterial Aneurysmal Subarachnoid Hemorrhage App 20180360787 - SUMMAR; Marshall L. ; et al.	2018-12-20
Citrulline for Treatment of Sickle Cell Crisis App 20180289647 - SUMMAR; Marshall L. ; et al.	2018-10-11
Sequelae of Cardiopulmonary Bypass-Induced Pulmonary Injury App 20180214403 - SUMMAR; Marshall L. ; et al.	2018-08-02
Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage Grant 9,943,494 - Summar , et al. April 17, 2	2018-04-17
Therapeutic Methods Employing Nitric Oxide Precursors App 20170119715 - SUMMAR; Marshall L. ; et al.	2017-05-04
Intravenous Administration Of Citrulline During Surgery App 20160374972 - SUMMAR; Marshall L. ; et al.	2016-12-29
Therapeutic Methods Employing Nitric Oxide Precursors App 20160317484 - Summar; Marshall L. ; et al.	2016-11-03
Therapeutic methods employing nitric oxide precursors Grant 8,536,225 - Summar , et al. September 17, 2	2013-09-17
Therapeutic Methods Employing Nitric Oxide Precursors App 20120252895 - Summar; Marshall L. ; et al.	2012-10-04
Therapeutic methods employing nitric oxide precursors Grant 8,188,147 - Summar , et al. May 29, 2	2012-05-29
Methods And Compositions For Treatment For Coronary And Arterial Aneurysmal Subarachnoid Hemorrhage App 20120088835 - Summar; Marshall L. ; et al.	2012-04-12
Therapeutic Treatment For Lung Conditions App 20090312423 - Summar; Marshall L. ; et al.	2009-12-17
Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage App 20090197964 - SUMMAR; MARSHALL L. ; et al.	2009-08-06
Therapeutic Methods Employing Nitric Oxide Precursors App 20080234379 - Summar; Marshall L. ; et al.	2008-09-25
Therapeutic methods employing nitric oxide precursors App 20040235953 - Summar, Marshall L. ; et al.	2004-11-25
Method for preventing hepatic encephalopathic episodes App 20040229948 - Summar, Marshall L. ; et al.	2004-11-18
Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism Grant 6,743,823 - Summar , et al. June 1, 2	2004-06-01
Method for treating hepatic encephalopathies App 20030195255 - Summar, Marshall L.	2003-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.